Women's Health

Allergan plans sales of women's health, infectious disease units
Allergan plans sales of women's health, infectious disease units
Reuters
Allergan
M&A
Women's Health
infectious diseases
Flag link:
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Teva closes $703m sale of global women’s health biz to CVC Capital
Teva closes $703m sale of global women’s health biz to CVC Capital
Drug Delivery Business News
Teva Pharmaceutical
Women's Health
M&A
CVC Capital
Flag link:
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Endpoints
Women's Health
KaNDy
Allergan
M&A
Flag link:
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Allergan
Repros
M&A
Women's Health
Flag link:
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Stat
drug pricing
Women's Health
Obamacare
healthcare reform
HHS
Alex Azar
Eli Lilly
Flag link:
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Cash-strapped Teva closes in on women's health sale No. 2: report
Cash-strapped Teva closes in on women's health sale No. 2: report
Fierce Pharma
Teva Pharmaceutical
Women's Health
M&A
CVC
Flag link:
Bidders line up for Teva's women's health unit in potential $2B sale
Bidders line up for Teva's women's health unit in potential $2B sale
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Flag link:
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Flag link:
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Motley Fool
Teva Pharmaceutical
M&A
Women's Health
oncology
Flag link:
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
M&A
Women's Health
oncology
Flag link:
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
Fierce Pharma
Teva Pharmaceutical
bribery
Women's Health
oncology
reorganization
Flag link:
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:
Birth Control Can Protect Women From Certain Cancers For Decades
Birth Control Can Protect Women From Certain Cancers For Decades
Forbes
birth control pill
contraceptives
Women's Health
Flag link:
FDA touts own role in women's heart health
FDA touts own role in women's heart health
BioPharma Dive
FDA
Women's Health
heart disease
Flag link:
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
Fierce Pharma
Amag Pharmaceuticals
Women's Health
hirings
drug reps
Intarosa
vaginal pain
Flag link:
Women’s health biotech ObsEva sets terms for $87M IPO
Women’s health biotech ObsEva sets terms for $87M IPO
Fierce Biotech
IPOs
ObsEva
Women's Health
Flag link:
Drugmakers revive R&D focus on long stagnant women's health market
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
R&D
Women's Health
innovation
Myovant Sciences
Amgen
UCB Pharma
breast cancer
Pfizer
S1 Biopharma
Ibrance
Addyi
Flag link:

Pages